tetano
Editor, Senior Moderator
Infect Control Hosp Epidemiol
. 2023 Jun 29;1-3.
doi: 10.1017/ice.2023.105. Online ahead of print. Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset
Jessica D Ferguson[SUP] 1 [/SUP], Ralph Tayyar[SUP] 1 [/SUP], Gustavo Contreras[SUP] 1 [/SUP], Melanie Kiener[SUP] 1 [/SUP], Alex N Zimmet[SUP] 1 [/SUP], Caitlin A Contag[SUP] 1 [/SUP], Guillermo Rodriguez Nava[SUP] 1 [/SUP], Lucy S Tompkins[SUP] 1 [/SUP], John Shepard[SUP] 1 [/SUP], Ayelet Rosenthal[SUP] 1 [/SUP], Aruna K Subramanian[SUP] 1 [/SUP], Benjamin A Pinsky[SUP] 1 [/SUP], Jorge L Salinas[SUP] 1 [/SUP]
Affiliations
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse-transcription polymerase chain reaction (rRT-PCR) strand-specific assay can be used to identify active SARS-CoV-2 viral replication. We describe the characteristics of 337 hospitalized patients with at least 1 minus-strand SARS-CoV-2 assay performed >20 days after illness onset. This test is a novel tool to identify high-risk hospitalized patients with prolonged SARS-CoV-2 replication.
. 2023 Jun 29;1-3.
doi: 10.1017/ice.2023.105. Online ahead of print. Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset
Jessica D Ferguson[SUP] 1 [/SUP], Ralph Tayyar[SUP] 1 [/SUP], Gustavo Contreras[SUP] 1 [/SUP], Melanie Kiener[SUP] 1 [/SUP], Alex N Zimmet[SUP] 1 [/SUP], Caitlin A Contag[SUP] 1 [/SUP], Guillermo Rodriguez Nava[SUP] 1 [/SUP], Lucy S Tompkins[SUP] 1 [/SUP], John Shepard[SUP] 1 [/SUP], Ayelet Rosenthal[SUP] 1 [/SUP], Aruna K Subramanian[SUP] 1 [/SUP], Benjamin A Pinsky[SUP] 1 [/SUP], Jorge L Salinas[SUP] 1 [/SUP]
Affiliations
- PMID: 37381726
- DOI: 10.1017/ice.2023.105
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse-transcription polymerase chain reaction (rRT-PCR) strand-specific assay can be used to identify active SARS-CoV-2 viral replication. We describe the characteristics of 337 hospitalized patients with at least 1 minus-strand SARS-CoV-2 assay performed >20 days after illness onset. This test is a novel tool to identify high-risk hospitalized patients with prolonged SARS-CoV-2 replication.